Downs syndrome patients four times more likely to develop type 2 diabetes

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-10-17 14:30 GMT | Update On 2022-10-18 07:24 GMT

A recent study found that young Downs syndrome patients have four times more incidence of type 2 diabetes than controls due to higher body mass index. The study was published in the journal Diabetes Care.

Down syndrome (DS) is the most common form of chromosomal trisomy. The risk of diabetes is increased by the genetic factors in DS. So, researchers conducted a study to determine whether DS is associated with an increased incidence of diabetes and the relationship with obesity across the lifespan compared with control patients. Based on the data from UK Clinical Practice Research Datalink, a population-based cohort study was performed and analyzed from 1990 to 2020.

Also, Read High protein, low carbohydrate diet reduces postprandial blood sugar in women with gestational diabetes

RESULTS

A total of 9,917 patients with DS and 38,266 control patients were analyzed.
Diabetes rates were higher in patients with DS and peaked at a younger age where the median age at diagnosis was 38 years in DS vs. 53 years in control patients.
Incidence rates for type 1 diabetes mellitus were 0.44 in patients with DS vs. 0.13 in control patients.
Type 2 diabetes mellitus (T2DM) rates were higher in patients with DS versus control patients in age-groups from 5 years up to 34 years.
In patients with DS, peak mean BMI was higher at a younger age versus control patients.

Downs syndrome	Control
Males - 31.2 kg/m2 at age 31 years	Males - 29.5 kg/m2 at 54 years
Females - 32.1 kg/m2 at 43 years	Females - 29.2 kg/m2 at 51 years

Obesity was associated with an increased incidence of T2DM.

Also Read: Thiazolidinediones may prevent dementia in high-risk patients of diabetes: BMJ

Thus, the study shows that the incidence of diabetes in patients with DS is higher and at a younger age than controls due to higher BMI.

Aisha A. Aslam, R. Asaad Baksh, Sarah E. Pape, Andre Strydom, Martin C. Gulliford, Li F. Chan, GO-DS21 Consortium; for the GO-DS21 Consortium, Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records. Diabetes Care 2022; dc220482. https://doi.org/10.2337/dc22-0482

Article Source : Diabetes Care

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr.Niharika Harsha B

Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Downs syndrome patients four times more likely to develop type 2 diabetes

Similar News

Dapagliflozin and Empagliflozin Shows Comparable Effectiveness in Type 2 Diabetes: Study

Coronary Microvascular Dysfunction Increases Risk of Heart Events in Diabetic Patients: Study

Breathing device could have profound impact on survival for people with sleep apnoea and type 2 diabetes

Early Metabolic Patterns in Prediabetes Help Predict Long-Term Complications: Study

EMA warns of sharp rise in illegal medicines sold in EU

Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study

Enavogliflozin Improves Adipokine Profile and Metabolic Health in T2DM: Study

Botanical-Based Hydrogel Promising in Treating Diabetic Foot Ulcers, Finds New Study